Apollo to invest €3bn in life sciences business Bayer
Friday, July 10, 2026 · first reported by PE Hub and 1 other
Apollo Global Management acquires €3bn minority stake in Bayer's long-acting reversible contraceptives business, expanding its strategic financing role to multinational corporations.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.